Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Aligos Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 18.77M | 73.76M | 37M | 35.33M | 45.15M | 24.37M | 135.77M | 70.43M | 90.83M | 78.67M | 81.35M | 86.44M | 71.17M | 104.56M | 186.82M | 239.73M | 187.65M | 200.36M |
Short-Term Investments | 104.28M | 64.1M | 19.94M | 39.59M | 49.46M | 88.59M | n/a | n/a | 10K | 24.84M | 44.48M | 55.86M | 88.17M | 78.66M | 3.92M | 2.45M | 3M | 13.05M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.11M | 492K | n/a | n/a |
Other Long-Term Assets | 640K | 632K | 2.38M | 635K | 631K | 625K | 625K | 623K | 624K | 632K | -2.53M | 653K | 616K | 616K | 866K | 748K | 1.48M | 188K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.89M | 5.34M | 5.2M | 4.9M | 5.03M | 5.11M | 5.38M | 4.21M | 3.4M | 5.91M | 7.72M | 7.79M | 8.34M | 11.85M | 13.69M | 6.49M | 5.99M | 6.41M |
Total Current Assets | 127.94M | 143.21M | 62.14M | 79.82M | 99.57M | 118.06M | 141.08M | 74.64M | 94.24M | 109.43M | 133.54M | 150.09M | 167.69M | 195.08M | 204.42M | 248.67M | 196.64M | 219.83M |
Property-Plant & Equipment | 6.12M | 6.86M | 7.33M | 7.97M | 8.61M | 9.21M | 9.82M | 10.59M | 11.26M | 11.68M | 12.51M | 13.32M | 14.22M | 14.78M | 14.97M | 13.16M | 13.75M | 14.53M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.77M | n/a | n/a | n/a |
Total Long-Term Assets | 6.76M | 7.49M | 9.71M | 8.6M | 9.24M | 9.84M | 12.82M | 11.21M | 11.89M | 12.31M | 13.15M | 13.98M | 14.84M | 15.39M | 30.95M | 14.4M | 15.23M | 14.71M |
Total Assets | 134.71M | 150.7M | 70.09M | 88.43M | 108.81M | 127.9M | 153.9M | 85.85M | 106.13M | 121.74M | 146.69M | 164.07M | 182.52M | 210.47M | 235.37M | 263.07M | 211.88M | 234.54M |
Account Payables | 3.94M | 4.46M | 2.57M | 2.74M | 6.82M | 2.84M | 2.52M | 2.94M | 3.24M | 2.82M | 4.74M | 2.93M | 2.76M | 3.75M | 3.02M | 2.6M | 1.59M | 2.81M |
Deferred Revenue | 579K | n/a | 151K | 655K | 1.33M | 1.33M | 1.31M | 3.95M | 6.95M | 7.03M | 9.21M | 10.72M | 13.13M | 15.07M | 7.64M | 6.64M | 6.81M | 7.58M |
Short-Term Debt | 3.54M | n/a | 3.46M | 3.4M | 3.35M | 3.35M | 3.24M | 3.25M | 3.24M | 3.15M | n/a | 3.21M | 2.93M | 3.29M | n/a | 2.78M | 2.63M | 2.56M |
Other Current Liabilities | 7.79M | 3.45M | 12.99M | 11.42M | 6M | 5.25M | 10.58M | 7.81M | 9.12M | 9.66M | 6.36M | 9.56M | 9.03M | 14.8M | 19.07M | 18.91M | 15.94M | 8.84M |
Total Current Liabilities | 20.27M | 18.95M | 21.74M | 20.96M | 23.56M | 23.56M | 23.91M | 22.47M | 27.23M | 28.08M | 33.13M | 30.54M | 31.65M | 41.36M | 38.96M | 34.78M | 30.1M | 25.23M |
Long-Term Debt | 3.34M | n/a | 4.92M | 5.73M | n/a | 6.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 9.24M | 10.92M | 74.17M | 11.64M | 11.54M | 42.02M | 30.02M | 46K | n/a | n/a | n/a | 133K | 133K | 134K | 133K | 267K | 267K | 267K |
Total Long-Term Liabilities | 12.57M | 15.31M | 79.09M | 17.37M | 18.02M | 49.23M | 37.92M | 8.56M | 9.27M | 8.91M | 9.66M | 11.52M | 13.89M | 16.23M | 11.68M | 11.28M | 12.89M | 14.09M |
Total Liabilities | 32.84M | 34.25M | 99.07M | 38.33M | 41.58M | 68.11M | 61.82M | 31.03M | 36.49M | 36.99M | 42.79M | 42.06M | 45.54M | 57.58M | 50.64M | 46.06M | 42.99M | 39.32M |
Total Debt | 6.88M | 7.87M | 8.38M | 9.13M | 9.84M | 9.84M | 11.14M | 11.77M | 12.41M | 11.96M | 12.57M | 13.03M | 13.44M | 14.38M | 14.46M | 12.42M | 12.53M | 12.87M |
Common Stock | 9K | 9K | 8K | 8K | 8K | 7K | 7K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -590.78M | -574.92M | -618.01M | -535.86M | -516.6M | -521.66M | -486.8M | -458.9M | -440.86M | -422.07M | -399.12M | -377.23M | -358.61M | -338.69M | -303.07M | -265.36M | -232.23M | -202.41M |
Comprehensive Income | 420K | 447K | 451K | 577K | 494K | 476K | 545K | 497K | 497K | 499K | 401K | 159K | 50K | 204K | 452K | -250K | -251K | -227K |
Shareholders Equity | 101.87M | 116.44M | -28.97M | 50.1M | 67.23M | 59.8M | 92.08M | 54.82M | 69.64M | 84.75M | 103.9M | 122.01M | 136.98M | 152.89M | 184.73M | 217.01M | 168.88M | 195.22M |
Total Investments | 104.28M | 64.1M | 19.94M | 39.59M | 49.46M | 88.59M | n/a | n/a | 10K | 24.84M | 44.48M | 55.86M | 88.17M | 78.66M | 19.03M | 2.94M | 3M | 13.05M |